{"title": "Historias esperanzadoras:Una terapia de c\u00e9lulas madre para la diabetes", "author": null, "url": "https://www.cirm.ca.gov/our-progress/historias-esperanzadorasuna-terapia-de-calulas-madre-para-la-diabetes/", "hostname": "cirm.ca.gov", "description": null, "sitename": "cirm.ca.gov", "date": "2023-06-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Historias esperanzadoras:Una terapia de c\u00e9lulas madre para la diabetes\nTranquilidad corporal y espiritual\nLo \u00faltimo que esperaba Mar\u00eda Torres era que la diagnosticaran con diabetes de tipo 2. Ella hac\u00eda ejercicio f\u00edsico, com\u00eda bien y manten\u00eda su peso bajo control. Ten\u00eda que haber alg\u00fan error. Mar\u00eda le pidi\u00f3 al m\u00e9dico que repitiera los ex\u00e1menes, pero los resultados fueron los mismos. A los 43 a\u00f1os de edad, por razones que nadie pod\u00eda explicar totalmente, ella padec\u00eda de diabetes, y su vida iba a cambiar dram\u00e1ticamente.\n\u201cRealmente me asust\u00f3\u201d, dice Mar\u00eda. \u201cPensaba que me iba a morir pronto\u201d.\nQue Mar\u00eda haya dudado de su diagn\u00f3stico no es sorprendente. La diabetes de tipo 2 se relaciona frecuentemente con la obesidad, y ella no encajaba dentro de esas caracter\u00edsticas. Lo m\u00e1s probable era que alg\u00fan componente gen\u00e9tico no descubierto la hubiera hecho susceptible a la enfermedad.\nEn cualquier caso, ahora ten\u00eda que replantearse su vida para controlar la diabetes. Sus c\u00e9lulas hab\u00edan desarrollado un problema llamado resistencia a la insulina. Aunque su p\u00e1ncreas produc\u00eda insulina, que transmite a las c\u00e9lulas el mensaje de que deben tomar az\u00facar de la sangre, las c\u00e9lulas no estaban cooperando. Como consecuencia, se acumulaba la glucosa en la sangre, poniendo a Mar\u00eda en peligro de una enfermedad card\u00edaca, da\u00f1o neural, problemas oculares y una serie de otros problemas.\nPara ayudar a que las c\u00e9lulas absorban glucosa, ella necesita regularmente inyecciones de insulina. Mar\u00eda se inyecta la hormona cinco veces al d\u00eda y debe medir sus niveles de az\u00facar en sangre a\u00fan m\u00e1s frecuentemente.\nSeguir fielmente este r\u00e9gimen la ha mantenido viva durante 20 a\u00f1os, pero la insulina no es una cura. Aun con las habituales inyecciones, se enfrenta a altibajos emocionales dr\u00e1sticos y a complicaciones m\u00e1s serias cuando los niveles de glucosa suben y bajan.\nTrabajando en pos de una cura\nUna de las estrategias m\u00e1s prometedoras para curar la diabetes es el trasplante de c\u00e9lulas beta, que detectan los niveles de glucosa en la sangre y producen insulina para reducirlos. Los pacientes con diabetes de tipo 1 se beneficiar\u00edan porque las nuevas c\u00e9lulas beta reemplazar\u00edan a las que se han perdido debido a la enfermedad. Los pacientes de tipo 2, como Mar\u00eda, podr\u00edan aumentar la capacidad de su cuerpo para producir insulina, bajando los niveles de az\u00facar en sangre y disminuyendo la necesidad de darse inyecciones.\nCon casi $40 millones en financiamiento del Instituto para la Medicina Regeneradora de California (California Institute for Regenerative Medicine) (CIRM, por sus siglas en ingl\u00e9s), una compa\u00f1\u00eda basada en San Diego llamada ViaCyte trabaja para lograr esta soluci\u00f3n. Han pasado a\u00f1os desarrollando nuevos m\u00e9todos para convertir c\u00e9lulas madre embrionarias en c\u00e9lulas beta que producen insulina. No ha sido f\u00e1cil. Las c\u00e9lulas madre son prometedoras porque pueden formar cualquier tejido. Sin embargo, para crear un tipo espec\u00edfico de c\u00e9lula, los investigadores deben repetir las se\u00f1ales exactas que transforman una c\u00e9lula madre en una c\u00e9lula beta, en lugar de convertirla en una c\u00e9lula neuronal o muscular.\nEn 2008, la compa\u00f1\u00eda alcanz\u00f3 su objetivo, pero con una vuelta ingeniosa. Crearon c\u00e9lulas progenitoras, a un paso de las c\u00e9lulas beta maduras, y les permitieron terminar de desarrollarse en el cuerpo. En estudios con animales, las c\u00e9lulas progenitoras m\u00e1s resistentes sobrevivieron el proceso de trasplante y, una vez maduras, comenzaron a producir insulina. El proyecto ofrece otra innovaci\u00f3n: estas c\u00e9lulas progenitoras se colocan primero en una c\u00e1psula porosa, de aproximadamente el tama\u00f1o de una tarjeta de cr\u00e9dito, antes de trasplantarse bajo la piel. Este dispositivo permite el traspaso de az\u00facar en sangre, insulina, ox\u00edgeno y otras mol\u00e9culas pero no deja pasar las c\u00e9lulas, de este modo evitando el posible ataque y rechazo por parte del propio sistema inmunitario del paciente.\nLa meta de ViaCyte es comenzar ensayos cl\u00ednicos para la diabetes de tipo 1 a fines del 2014. Pero, con el tiempo, la compa\u00f1\u00eda tambi\u00e9n quiere ayudar a aquellos que padecen de diabetes tipo 2. Mar\u00eda Torres est\u00e1 deseosa de que estos ensayos tengan resultados exitosos, tanto para s\u00ed misma como para su familia.\n\u201cTengo tres hijos y s\u00e9 que pueden tener lo mismo que yo\u201d, dice Mar\u00eda. \u201cSi descubren un tratamiento, para m\u00ed, eso significar\u00e1 tranquilidad\u201d.\nPara obtener informaci\u00f3n adicional sobre la investigaci\u00f3n financiada por CIRM sobre la diabetes,\n[visite nuestra hoja informativa](/our-progress/type-1-diabetes-fact-sheet).", "language": null, "image": null, "pagetype": null, "links": ["https://www.facebook.com/CaliforniaInstituteForRegenerativeMedicine", "https://www.instagram.com/cirmnews/", "https://twitter.com/cirmnews", "https://www.youtube.com/user/CIRMTV", "/our-progress/cirm-rss-feeds", "https://www.linkedin.com/company/california-institute-for-regenerative-medicine/", "https://www.flickr.com/photos/cirm", "/", "/researchers", "/researchers/funding-opportunities", "/information-for-applicants", "/researchers/funding-opportunities", "/our-funding/covid-19", "/discovery", "/translational", "/researchers/funding-opportunities/clinical-trial-stage-projects", "/researchers/funding-opportunities/infrastructure", "/about-cirm/education-conference-grants-and-research-training-awards", "/our-funding/previous-funding-opportunities", "/grants", "/active-awards-portfolio", "/grants", "/researchers/managing-your-grant", "/our-progress/people-we-funded", "/our-progress/funded-institutions", "/our-progress/cirm-funding-commitments", "/our-funding/cirm-stem-cell-grant-regulations", "/researchers/clinical-resources", "/our-impact/funding-clinical-trials", "/patients/alpha-clinics-network", "/researchers/cell-and-gene-therapy-center", "/our-funding/collaborative-funding-partners", "/researchers/research-resources", "/about-cirm/faqs-cirm-awards", "/our-progress/industry-alliance-program", "/researchers/ipsc-repository", "http://cirm.ucsc.edu/", "/publications", "/about-cirm/publications-by-grantees", "/our-funding/webinars-and-workshops", "/our-funding/human-embryonic-stem-cell-hesc-lines", "/patients", "/patients", "/our-impact/funding-clinical-trials", "/patients/alpha-clinics-network", "/our-progress/cirm-stem-cell-champions", "/patients/disease-information", "/patients/stories-hope", "https://blog.cirm.ca.gov/", "/our-progress/stem-cell-videos", "/patients/stem-cell-basics", "/patients/stem-cell-key-terms", "/patients/creating-new-types-stem-cells", "/patients/accelerating-research-towards-cures", "/patients/california-leader-stem-cell-research", "/patients/lab-bench-clinic-bedside", "/patients/myths-and-misconceptions-about-stem-cell-research", "/patients/stem-cell-tourism", "/patients/power-stem-cells", "/patients/patients-toolbox", "/patients/get-involved", "/patients/patients-toolbox/talking-about-cirm", "/patients/patients-toolbox/jargon-free-glossary", "/patients/patients-toolbox/media-interviews", "/patients/patients-toolbox/delivering-perfect-presentation", "/patients/patients-toolbox/moderating-panel", "/patients/patients-toolbox/serving-panel", "/patients/patients-toolbox/participating-clinical-trial", "/our-impact", "/our-impact", "/active-awards-portfolio", "/clinical-trials", "/our-impact/return-investment", "/our-impact/creating-jobs", "/our-impact/creating-infrastructure", "/our-impact/growing-field", "/about-cirm/strategic-plan-2022-2027", "/education", "/our-impact/internship-programs", "/our-progress/stem-cell-education-portal-landing", "/our-impact/training-tomorrows-scientists", "/our-impact/community", "/our-progress/cirm-stem-cell-champions", "/our-progress/stem-cell-awareness-day", "/patients/get-involved", "/about-cirm", "/about-cirm", "/about-cirm/our-mission", "/about-cirm/cirm-leadership", "/about-cirm/history", "/annual-report-2023/", "/about-cirm/cirm-faq", "/about/where-cirm-funding-goes", "/about-cirm/employment-opportunities", "/about-cirm/contact-us", "/board-and-meetings", "/board-and-meetings", "/board-and-meetings/public-meetings", "/about-cirm/cirm2.0", "/about-cirm/cirm-annual-reports/", "/about-cirm/strategic-plan-2022-2027", "/researchers/funding-opportunities", "/about-cirm/administrative-policies-and-forms", "/about-cirm/newsroom", "/about-cirm/newsroom", "/about-cirm/newsroom", "/meetings-and-events", "/board-and-meetings/public-meetings", "/board-and-meetings/board", "https://blog.cirm.ca.gov/", "https://blog.cirm.ca.gov/", "/about-cirm/media-resources", "https://www.buzzsprout.com/1666651", "/our-progress/stem-cell-videos", "https://www.flickr.com/photos/cirm", "/wp-content/uploads/archive/CIRM-Fact-Sheet-2022.pdf", "/about-cirm/cirm-logos", "/about-cirm/contact-us", "/our-progress/stories-hope-stem-cell-therapy-diabetes", "/our-progress/type-1-diabetes-fact-sheet", "/researchers", "/researchers/funding-opportunities", "/information-for-applicants", "/researchers/funding-opportunities", "/our-funding/covid-19", "/discovery", "/translational", "/researchers/funding-opportunities/clinical-trial-stage-projects", "/researchers/funding-opportunities/infrastructure", "/about-cirm/education-conference-grants-and-research-training-awards", "/our-funding/previous-funding-opportunities", "/grants", "/active-awards-portfolio", "/grants", "/researchers/managing-your-grant", "/our-progress/people-we-funded", "/our-progress/funded-institutions", "/our-progress/cirm-funding-commitments", "/our-funding/cirm-stem-cell-grant-regulations", "/researchers/clinical-resources", "/our-impact/funding-clinical-trials", "/patients/alpha-clinics-network", "/researchers/cell-and-gene-therapy-center", "/our-funding/collaborative-funding-partners", "/researchers/research-resources", "/about-cirm/faqs-cirm-awards", "/our-progress/industry-alliance-program", "/researchers/ipsc-repository", "http://cirm.ucsc.edu/", "/publications", "/about-cirm/publications-by-grantees", "/our-funding/webinars-and-workshops", "/our-funding/human-embryonic-stem-cell-hesc-lines", "/about-cirm", "/about-cirm", "/about-cirm/our-mission", "/about-cirm/cirm-leadership", "/about-cirm/history", "/about-cirm/cirm-annual-reports", "/about-cirm/cirm-faq", "/about/where-cirm-funding-goes", "/about-cirm/employment-opportunities", "/about-cirm/contact-us", "/board-and-meetings", "/board-and-meetings/public-meetings", "/about-cirm/cirm2.0", "/about-cirm/cirm-annual-reports", "/about-cirm/strategic-plan-2022-2027", "/researchers/funding-opportunities", "/about-cirm/administrative-policies-and-forms", "https://www.facebook.com/CaliforniaInstituteForRegenerativeMedicine", "https://www.instagram.com/cirm_stemcells/", "https://twitter.com/cirmnews", "https://www.youtube.com/user/CIRMTV", "https://www.cirm.ca.gov/our-progress/cirm-rss-feeds", "https://www.linkedin.com/groups?gid=4017737&trk=myg_ugrp_ovr", "https://www.flickr.com/photos/cirm", "/patients", "/patients", "/our-impact/funding-clinical-trials", "/patients/alpha-clinics-network", "/our-progress/cirm-stem-cell-champions", "/patients/disease-information", "/patients/stories-hope", "https://blog.cirm.ca.gov/", "/our-progress/stem-cell-videos", "/patients/stem-cell-basics", "/patients/stem-cell-key-terms", "/patients/creating-new-types-stem-cells", "/patients/accelerating-research-towards-cures", "/patients/california-leader-stem-cell-research", "/patients/lab-bench-clinic-bedside", "/patients/myths-and-misconceptions-about-stem-cell-research", "/patients/stem-cell-tourism", "/patients/power-stem-cells", "/patients/patients-toolbox", "/patients/get-involved", "/patients/patients-toolbox/talking-about-cirm", "/patients/patients-toolbox/jargon-free-glossary", "/patients/patients-toolbox/media-interviews", "/patients/patients-toolbox/delivering-perfect-presentation", "/patients/patients-toolbox/moderating-panel", "/patients/patients-toolbox/serving-panel", "/patients/patients-toolbox/participating-clinical-trial", "/about-cirm/newsroom", "/about-cirm/newsroom", "/meetings-and-events", "/board-and-meetings/public-meetings", "/board-and-meetings/board", "https://blog.cirm.ca.gov/", "/about-cirm/media-resources", "https://www.buzzsprout.com/1666651", "/our-progress/stem-cell-videos", "https://www.flickr.com/photos/cirm", "https://www.cirm.ca.gov/sites/default/files/CIRM-Fact-Sheet-2022.pdf", "/about-cirm/cirm-logos", "/our-impact", "/our-impact", "/active-awards-portfolio", "/clinical-trials", "/our-impact/return-investment", "/our-impact/creating-jobs", "/our-impact/creating-infrastructure", "/about-cirm/strategic-plan-2022-2027", "/education", "/our-impact/internship-programs", "/our-progress/stem-cell-education-portal-landing", "/our-impact/training-tomorrows-scientists", "/our-impact/community", "/our-progress/cirm-stem-cell-champions", "/our-progress/stem-cell-awareness-day", "/patients/get-involved", "/about-cirm/contact-us/", "/about-cirm/contact-us/", "/wp-content/uploads/archive/CIRM_privacy_policy.pdf", "/about-cirm/accessibility/"]}